| Cigna EviCore | MOL.CU.333.B: Medically Necessary Laboratory Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.124.A: Alpha-1 Antitrypsin Deficiency Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.125.A: Amyotrophic Lateral Sclerosis (ALS) Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.126.A: Angelman Syndrome Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.144.A: CADASIL Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.148.A: Charcot-Marie-Tooth Neuropathy Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.150.A: Chromosomal Microarray Testing For Developmental Disorders (Prenatal and Postnatal) | 2026-01-01 |
| Cigna EviCore | MOL.TS.158.A: Cystic Fibrosis Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.162.A: Early Onset Familial Alzheimer Disease Genetic Testing | 2026-01-01 |
| Cigna EviCore | MOL.TS.168.A: Familial Adenomatous Polyposis Genetic Testing | 2026-01-01 |